LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities

LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology

LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers

LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT)

LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT)